Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Schizophrenia Research

• Publication date

  2017-07-19

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.schres.2017.06.059PMID 28734907
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain Structure Biomarkers in the Psychosis Biotypes: Findings From the Bipolar-Schizophrenia Network for Intermediate Phenotypes.

  2017cited by this paper
• Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.

  2015cited by this paper
• Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder.

  2015cited by this paper
• Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study.

  2015cited by this paper
• Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: a meta-analysis.

  2015cited by this paper
• BDNF and synaptic plasticity, cognitive function, and dysfunction.

  2014cited by this paper
• Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study.

  2013cited by this paper
• BDNF-TrkB signaling and neuroprotection in schizophrenia.

  2013cited by this paper
• Biomarkers in Schizophrenia: A Brief Conceptual Consideration

  2013cited by this paper
• Increases in two truncated TrkB isoforms in the prefrontal cortex of people with schizophrenia.

  2013cited by this paper
• Inflammation in Patients with Schizophrenia: The Therapeutic Benefits of Risperidone Plus Add-On Dextromethorphan

  2012cited by this paper
• Reliable biomarkers and predictors of schizophrenia and its treatment.

  2012cited by this paper
• Plasma BDNF Levels Vary in Relation to Body Weight in Females

  2012cited by this paper
• Brain-derived neurotrophic factor: findings in schizophrenia

  2011cited by this paper
• Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders.

  2011cited by this paper
• Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology.

  2010cited by this paper
• Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics

  2010cited by this paper
• Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics

  2010cited by this paper
• Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients

  2010cited by this paper
• Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survival

  2009cited by this paper
• Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?

  2009cited by this paper
• Decreased neurotrophic response to birth hypoxia in the etiology of schizophrenia.

  2008cited by this paper
• Brain-Derived Neurotropic Factor/TrkB Signaling in the Pathogenesis and Novel Pharmacotherapy of Schizophrenia

  2008cited by this paper
• Neurotrophins and schizophrenia.

  2007cited by this paper
• Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients.

  2007cited by this paper
• Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia

  2005cited by this paper
• Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.

  2005cited by this paper
• ProBDNF Induces Neuronal Apoptosis via Activation of a Receptor Complex of p75NTR and Sortilin

  2005cited by this paper
• Activation of p75NTR by proBDNF facilitates hippocampal long-term depression

  2005cited by this paper
• Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.

  2004cited by this paper
• Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia

  2003cited by this paper
• New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis.

  2003cited by this paper
• Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats

  2002cited by this paper
• A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.

  2002cited by this paper
• Long-term environmental enrichment leads to regional increases in neurotrophin levels in rat brain.

  2000cited by this paper
• Involvement of Brain-Derived Neurotrophic Factor in Spatial Memory Formation and Maintenance in a Radial Arm Maze Test in Rats

  2000cited by this paper
• Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment.

  1997cited by this paper
• Learning Deficit in BDNF Mutant Mice

  1997cited by this paper
• Drug therapy : schizophrenia

  1996cited by this paper
• Neuroleptic withdrawal in schizophrenic patients. A review of the literature.

  1995cited by this paper
• Neuroleptic withdrawal in schizophrenic patients.

  1995cited by this paper
• Duration of psychosis and outcome in first-episode schizophrenia.

  1992cited by this paper
• Neuroleptics and the natural course of schizophrenia.

  1991cited by this paper

• Alteration pattern of serum albumin levels in schizophrenia from first episode through remission to relapse: a longitudinal study.

  2026cites this paper
• Impact of Relapse in BDNF Receptors Expression in Patients With a First Episode of Schizophrenia.

  2025cites this paper
• The multiomics landscape of plasma exosomes in first-episode drug-naïve of schizophrenia

  2025cites this paper
• Relationship Between the Duration of Hospitalization and Readmission Status in Patients With Schizophrenia: A Saudi Arabian Cohort Study

  2025cites this paper
• Prediction of relapse in a French cohort of outpatients with schizophrenia (FACE-SZ): Prediction, not association.

  2025cites this paper
• Psychotic relapse prediction via biomarker monitoring: a systematic review

  2024cites this paper
• Brain-Derived Neurotrophic Factor (BDNF) and First-Episode Psychosis. A longitudinal one-year prognosis study

  2023cites this paper
• Rewiring neural circuits: Meditation based neurofeedback and its neuroplastic effects on the pathological brain

  2023cites this paper
• The polygenic basis of relapse after a first episode of schizophrenia.

  2023cites this paper
• Neuroprotective factors in schizophrenia: BDNF, NGF, NT3, GDNF and their connection to the pathogenesis of schizophrenia. A narrative review

  2023cites this paper
• Brain-derived neurotrophic factor (BDNF) in schizophrenia research: a quantitative review and future directions

  2023cites this paper
• Longitudinal study of inflammation and relapse in schizophrenia.

  2023cites this paper
• Increased brain gyrification and subsequent relapse in patients with first-episode schizophrenia

  2022cites this paper
• Unraveiling the correlation among neurodevelopmental and inflammatory biomarkers in patients with chronic schizophrenia

  2022cites this paper
• The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study.

  2022cites this paper
• Acute administration of a dopamine D2/D3 receptor agonist alters behavioral and neural parameters in adult zebrafish

  2022cites this paper
• A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood

  2021cites this paper
• Structure and predictors of in-hospital nursing care leading to reduction in early readmission among patients with schizophrenia in Japan: A cross-sectional study

  2021cites this paper
• Relationship Between Sense of Coherence and Social Support and Psychological Well-being Among Patients with Schizophrenia

  2021cites this paper
• Elevated environmental PM2.5 increases risk of schizophrenia relapse: Mediation of inflammatory cytokines.

  2020cites this paper
• Predicting relapse with residual symptoms in schizophrenia: A secondary analysis of the PROACTIVE trial.

  2020cites this paper
• Elevated brain-derived neurotrophic factor (BDNF) serum levels in an acute episode of schizophrenia in polish women: Correlation with clinical and metabolic parameters.

  2019cites this paper
• Transcriptomic analysis reveals oxidative phosphorylation activation in an adolescent social isolation rat model.

  2018cites this paper
• Effects of Risperidone and Paliperidone on Brain-Derived Neurotrophic Factor and N400 in First-Episode Schizophrenia

  2018cites this paper
• Decreased IL-1ra and NCAM-1/CD56 Serum Levels in Unmedicated Patients with Schizophrenia Before and After Antipsychotic Treatment

  2018cites this paper